Spevigo®

Understanding Spevigo® 

Spevigo® (spesolimab-sbzo) is an intravenous (IV) therapy approved for the treatment of generalized pustular psoriasis (GPP) flares in adult patients. This therapy is designed to rapidly address acute GPP flares by targeting the underlying inflammatory pathways, helping to reduce symptoms, control flare-ups, and improve patient outcomesduring episodes of GPP.

How Spevigo® Works:

• Targets the underlying inflammatory process in GPP
• Helps reduce symptoms and flare severity
• Improves patient outcomes during acute GPP flare-ups

FDA Approval:

• Spevigo® (spesolimab-sbzo): Approved for the treatment of GPP flares in adult patients

For more information, please visit the Spevigo® patient website and speak with your healthcare provider to determine if Spevigo® is the right treatment option for you.